Platelet-derived growth factor receptor expression after neural grafting in a rat model of Parkinson's disease.
Platelet-derived growth factor (PDGF) has trophic effect on dopaminergic neurons in vitro. We have previously shown dynamic changes in the expression of PDGF in embryonic mesencephalic grafts and surrounding host striatal tissue following intracerebral transplantation in a rat model of Parkinson's disease. In this study the expression of the PDGF receptors was examined in the same model using immunohistochemistry. Most ventral mesencephalic (VM) cells from E13-E15 rat embryos possessed both PDGF alpha- and beta-receptors before implantation. Double immunofluorescence staining revealed that about 10% of the cells also expressed tyrosine hydroxylase (TH). The PDGF alpha-receptor was detectable in the graft up to 1 wk after transplantation but had disappeared at 3 wk. In the host tissue, scattered glial cells were positive for the alpha-receptor but the expression was unchanged following transplantation. The beta-receptor expression almost completely disappeared from the grafted tissue by 4 h following transplantation, and only a few cells of the host striatum showed immunoreactivity. However, after 3 wk beta-receptor positive cells were again detectable in the graft. These cells appeared to be endothelial cells as identified by an antibody against von Willebrand's factor. Our data suggest that PDGF might act locally on embryonic dopaminergic cells in an autocrine or juxtacrine manner before and shortly after transplantation, and on surrounding glial cells in a paracrine manner after transplantation. Furthermore, PDGF-BB might influence neovascularization in the graft.
Ballagi
A E
AE
Ludwig Institute for Cancer Research, Biomedical Center, Uppsala, Sweden.
Odin
P
P
Othberg-Cederström
A
A
Smits
A
A
Duan
W M
WM
Lindvall
O
O
Funa
K
K
D000818:Animals; D001921:Brain / Q000378:metabolism*; D016380:Brain Tissue Transplantation / Q000502:physiology*; D002478:Cells, Cultured; D003342:Corpus Striatum / Q000378:metabolism; D004622:Embryo, Mammalian; D005260:Female; D016332:Fetal Tissue Transplantation / Q000502:physiology*; D005455:Fluorescent Antibody Technique; D015870:Gene Expression; D007124:Immunoenzyme Techniques; D008636:Mesencephalon / Q000378:metabolism / Q000637:transplantation*; D009474:Neurons / Q000378:metabolism*; D016627:Oxidopamine; D010302:Parkinson Disease, Secondary / Q000628:therapy*; D051381:Rats; D017207:Rats, Sprague-Dawley; D017479:Receptors, Platelet-Derived Growth Factor / Q000032:analysis / Q000096:biosynthesis*; D012016:Reference Values; D014185:Transplantation, Isogeneic; D014446:Tyrosine 3-Monooxygenase / Q000032:analysis / Q000096:biosynthesis
D016627:Oxidopamine; D014446:Tyrosine 3-Monooxygenase; D017479:Receptors, Platelet-Derived Growth Factor